298 related articles for article (PubMed ID: 35967738)
21. Nucleus-Targeting Manganese Dioxide Nanoparticles Coated with the Human Umbilical Cord Mesenchymal Stem Cell Membrane for Cancer Cell Therapy.
Xie L; Zhang C; Liu M; Huang J; Jin X; Zhu C; Lv M; Yang N; Chen S; Shao M; Du X; Feng G
ACS Appl Mater Interfaces; 2023 Mar; 15(8):10541-10553. PubMed ID: 36787533
[TBL] [Abstract][Full Text] [Related]
22. Surface modification potentials of cell membrane-based materials for targeted therapies: a chemotherapy-focused review.
Duan H; Wang L; Wang S; He Y
Nanomedicine (Lond); 2023 Aug; 18(19):1281-1303. PubMed ID: 37753724
[TBL] [Abstract][Full Text] [Related]
23. Biocompatible polymer-coated magneto-fluorescent super nanoparticles for the homing of mesenchymal stem cells.
Dash S; Majood M; Meena R; Mukherjee M; Dinda AK; Kuanr BK; Mohanty S
Int J Biol Macromol; 2024 Jun; 273(Pt 1):132794. PubMed ID: 38834114
[TBL] [Abstract][Full Text] [Related]
24. Erythrocytes Nanoparticle Delivery: A Boon for Targeting Tumor.
Siddique AR; Bhagwat GS
Adv Pharm Bull; 2024 Mar; 14(1):132-146. PubMed ID: 38585450
[TBL] [Abstract][Full Text] [Related]
25. Surface Functionalization of Polymeric Nanoparticles with Umbilical Cord-Derived Mesenchymal Stem Cell Membrane for Tumor-Targeted Therapy.
Yang N; Ding Y; Zhang Y; Wang B; Zhao X; Cheng K; Huang Y; Taleb M; Zhao J; Dong WF; Zhang L; Nie G
ACS Appl Mater Interfaces; 2018 Jul; 10(27):22963-22973. PubMed ID: 29905067
[TBL] [Abstract][Full Text] [Related]
26. Recent advances in biomimetic cell membrane-camouflaged nanoparticles for cancer therapy.
Alimohammadvand S; Kaveh Zenjanab M; Mashinchian M; Shayegh J; Jahanban-Esfahlan R
Biomed Pharmacother; 2024 Jun; 177():116951. PubMed ID: 38901207
[TBL] [Abstract][Full Text] [Related]
27. "Nanodecoys" - Future of drug delivery by encapsulating nanoparticles in natural cell membranes.
Imran M; Jha LA; Hasan N; Shrestha J; Pangeni R; Parvez N; Mohammed Y; Jha SK; Paudel KR
Int J Pharm; 2022 Jun; 621():121790. PubMed ID: 35504432
[TBL] [Abstract][Full Text] [Related]
28. Recent advances in erythrocyte membrane-camouflaged nanoparticles for the delivery of anti-cancer therapeutics.
Wang S; Wang Y; Jin K; Zhang B; Peng S; Nayak AK; Pang Z
Expert Opin Drug Deliv; 2022 Aug; 19(8):965-984. PubMed ID: 35917435
[TBL] [Abstract][Full Text] [Related]
29. RBC membrane camouflaged prussian blue nanoparticles for gamabutolin loading and combined chemo/photothermal therapy of breast cancer.
Liu B; Wang W; Fan J; Long Y; Xiao F; Daniyal M; Tong C; Xie Q; Jian Y; Li B; Ma X; Wang W
Biomaterials; 2019 Oct; 217():119301. PubMed ID: 31279101
[TBL] [Abstract][Full Text] [Related]
30. Copper sulfide nanoparticle-based localized drug delivery system as an effective cancer synergistic treatment and theranostic platform.
Hou L; Shan X; Hao L; Feng Q; Zhang Z
Acta Biomater; 2017 May; 54():307-320. PubMed ID: 28274767
[TBL] [Abstract][Full Text] [Related]
31. Research update on cell membrane camouflaged nanoparticles for cancer therapy.
Wang C; Wu S
Front Bioeng Biotechnol; 2022; 10():944518. PubMed ID: 35992357
[TBL] [Abstract][Full Text] [Related]
32. Erythrocyte-Cancer Hybrid Membrane Camouflaged Hollow Copper Sulfide Nanoparticles for Prolonged Circulation Life and Homotypic-Targeting Photothermal/Chemotherapy of Melanoma.
Wang D; Dong H; Li M; Cao Y; Yang F; Zhang K; Dai W; Wang C; Zhang X
ACS Nano; 2018 Jun; 12(6):5241-5252. PubMed ID: 29800517
[TBL] [Abstract][Full Text] [Related]
33. The Emerging Role of Cell Membrane-coated Nanomaterials in Cancer Therapy.
Bhattacharya S; Beninger P
Curr Pharm Des; 2024 Mar; ():. PubMed ID: 38441015
[TBL] [Abstract][Full Text] [Related]
34. Melanoma Peptide MHC Specific TCR Expressing T-Cell Membrane Camouflaged PLGA Nanoparticles for Treatment of Melanoma Skin Cancer.
Yaman S; Ramachandramoorthy H; Oter G; Zhukova D; Nguyen T; Sabnani MK; Weidanz JA; Nguyen KT
Front Bioeng Biotechnol; 2020; 8():943. PubMed ID: 32850765
[TBL] [Abstract][Full Text] [Related]
35. An effective intracellular delivery system of monoclonal antibody for treatment of tumors: erythrocyte membrane-coated self-associated antibody nanoparticles.
Gao L; Han L; Ding X; Xu J; Wang J; Zhu J; Lu W; Sun J; Yu L; Yan Z; Wang Y
Nanotechnology; 2017 Aug; 28(33):335101. PubMed ID: 28657549
[TBL] [Abstract][Full Text] [Related]
36. Advancements in cell membrane camouflaged nanoparticles: A bioinspired platform for cancer therapy.
Dhas N; García MC; Kudarha R; Pandey A; Nikam AN; Gopalan D; Fernandes G; Soman S; Kulkarni S; Seetharam RN; Tiwari R; Wairkar S; Pardeshi C; Mutalik S
J Control Release; 2022 Jun; 346():71-97. PubMed ID: 35439581
[TBL] [Abstract][Full Text] [Related]
37. Hybrid Membrane Camouflaged Chemodrug-Gene Nanoparticles for Enhanced Combination Therapy of Ovarian Cancer.
Chen T; Wang Y; Zhu L; Wu J; Lin J; Huang W; Yan D
ACS Appl Mater Interfaces; 2023 Dec; 15(50):58067-58078. PubMed ID: 38056905
[TBL] [Abstract][Full Text] [Related]
38. Cell membrane camouflaged bismuth nanoparticles for targeted photothermal therapy of homotypic tumors.
Ren X; Yang S; Yu N; Sharjeel A; Jiang Q; Macharia DK; Yan H; Lu C; Geng P; Chen Z
J Colloid Interface Sci; 2021 Jun; 591():229-238. PubMed ID: 33609894
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
